The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Market Value Trend Is Expected For The Biopharmaceutical Excipients Market From 2026 To 2030?
The biopharmaceutical excipients market size has seen significant growth over recent years. It is projected to expand from $3.27 billion in 2025 to $3.57 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 9.2%. The historical period’s expansion was driven by increasing biologic drug approvals, early adoption of protein stabilizers, growth in injectable formulations, the expansion of vaccine development, and advancements in formulation science.
The biopharmaceutical excipients market is anticipated to experience robust expansion over the coming years. Its valuation is projected to reach $5.04 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.0%. This projected growth stems from several factors, including the increasing intricacy of biologic formulations, a surging need for products with extended shelf lives, the broadening scope of cell and gene therapies, heightened regulatory scrutiny on excipient safety, and greater investments in sophisticated drug delivery systems. Key developments expected during this timeframe encompass a rising requirement for high-purity biologic excipients, the broader adoption of multifunctional formulation components, an increase in excipients tailored for cell and gene therapies, an intensifying emphasis on compounds that enhance stability, and greater personalization of excipient offerings.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=30214&type=smp
What Primary Factors Are Fueling The Expansion Of The Biopharmaceutical Excipients Market?
The anticipated expansion of the biopharmaceutical excipients market is linked to the increasing need for vaccine development moving forward. Vaccine development involves creating and formulating immunizations to prevent infectious diseases and enhance public health, relying on premium excipients to guarantee the stability, effectiveness, and safety of these products. This rising demand for vaccine development arises from a worldwide emphasis on preventing infectious diseases, bolstering public health readiness, and expediting research to provide more rapid and potent immunization options. Within vaccine formulations, biopharmaceutical excipients serve a crucial function by stabilizing antigens, improving solubility, and preserving integrity throughout storage and distribution. For example, in 2025, according to the Centers for Disease Control and Prevention, a US-based national public health agency, adolescent vaccination coverage for key vaccines such as tetanus, diphtheria, and acellular pertussis increased from 89.9% in 2022 to 91.3% in 2024, meningococcal conjugate vaccine coverage rose from 88.6% to 90.1%; and human papillomavirus vaccine coverage (=2 doses) grew significantly from 76.0% to 92.6% over the same period. Consequently, the increasing need for vaccine development is fueling the expansion of the biopharmaceutical excipients market.
What Segment Categories Are Evaluated In The Biopharmaceutical Excipients Market Study?
The biopharmaceutical excipients market covered in this report is segmented –
1) By Product Types: Binders, Coatings, Diluents, Disintegrants, Lubricants And Glidants, Polyols, Preservatives, Solubilizers And Surfactants Or Emulsifiers, Suspending And Viscosity Agents
2) By Type Of Biologics: Antibodies, Vaccines, Cell Therapies, Other Biologics
3) By Functionality: Fillers And Diluents, Binders, Suspending And Viscosity Agents, Flavouring Agents And Sweeteners, Coating Agents, Colourants, Disintegrants, Lubricants And Glidants, Preservatives
4) By Application: Injectable Formulations, Oral Formulations, Topical Formulations, Transdermal Formulations, Cell and Gene Therapy
5) By End Users: Biopharmaceutical Companies And Pharmaceutical Companies, Contract Manufacturers, Research Institutes
Subsegments:
1) By Binders: Starch Binders, Cellulose Binders, Synthetic Binders, Natural Polymer Binders
2) By Coatings: Film Coatings, Sugar Coatings, Enteric Coatings, Polymer Coatings
3) By Diluents: Lactose, Microcrystalline Cellulose, Starch, Mannitol
4) By Disintegrants: Crosslinked Cellulose, Starch Derivatives, Crospovidone, Sodium Starch Glycolate
5) By Lubricants And Glidants: Magnesium Stearate, Stearic Acid, Talc, Silicon Dioxide
6) By Polyols: Sorbitol, Mannitol, Glycerol, Xylitol
7) By Preservatives: Parabens, Benzoates, Sorbates, Phenols
8) By Solubilizers And Surfactants Or Emulsifiers: Polysorbates, Polyethylene Glycol, Lecithin, Sodium Lauryl Sulfate
9) By Suspending And Viscosity Agents: Cellulose Derivatives, Xanthan Gum, Guar Gum, Carbomers
What Trends Are Affecting The Biopharmaceutical Excipients Market Dynamics?
Key players in the biopharmaceutical excipients market are prioritizing technological advancements, such as ultra-high purity surfactants, to improve protein stability, prevent degradation, and support regulatory adherence in injectable formulations. Ultra-high purity surfactants are specifically refined surface-active agents with minimal impurities and a consistent composition, engineered to ensure stability, safety, and performance in sensitive pharmaceutical and biopharmaceutical preparations. For instance, in September 2025, Evonik Industries AG, a Germany-based chemicals company, unveiled MaxiPure Polysorbate 80 for injectable and biopharmaceutical applications. This excipient is designed with an oleic acid content exceeding ninety-eight percent, superior clarity, and full compliance with European Pharmacopoeia, United States Pharmacopoeia, Japanese Pharmacopoeia, and Chinese Pharmacopoeia standards. It addresses significant challenges in protein stability, prevents oxidative degradation, facilitates consistent solubilization of hydrophobic active pharmaceutical ingredients, and enhances formulation reliability. Through the integration of this excipient, Evonik empowers pharmaceutical and biopharmaceutical companies to efficiently develop complex biologics and injectable therapies while guaranteeing safety and compliance.
Who Are The Leading Firms Participating In The Biopharmaceutical Excipients Market?
Major companies operating in the biopharmaceutical excipients market are The Archer-Daniels-Midland Company, BASF SE, The Dow Chemical Company, Mitsubishi Chemical Group Corporation, Novo Nordisk A/S, Associated British Foods plc, Merck KGaA, Asahi Kasei Corporation, Evonik Industries AG, Kerry Group plc, Wacker Chemie AG, Clariant AG, Shin-Etsu Chemical Co. Ltd., Roquette Frères, IMCD Group N.V., Croda International Plc, Ashland Global Holdings Inc., NOF Corporation, Colorcon Limited, J. Rettenmaier & Söhne GmbH + Co. KG, Spectrum Chemical Manufacturing Corporation, BioSpectra Inc., Sigachi Industries Limited, DFE Pharma, FUJIFILM Toyama Chemical Co. Ltd, Kirsch Pharma GmbH, Meggle Group GmbH, InVitria Inc., BOC Sciences Inc.
Access The Complete Biopharmaceutical Excipients Market Report:
https://www.thebusinessresearchcompany.com/report/global-biopharmaceutical-excipients-market-report
Which Region Contributes The Most To The Biopharmaceutical Excipients Market?
North America was the largest region in the biopharmaceutical excipients market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biopharmaceutical excipients market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Biopharmaceutical Excipients Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=30214&type=smp
Browse Through More Reports Similar to the Global Biopharmaceutical Excipients Market 2026, By The Business Research Company
Pharmaceutical Excipient Market Report 2026
https://www.thebusinessresearchcompany.com/report/pharmaceutical-excipient-global-market-report
Organic Pharmaceutical Excipients Market Report 2026
Nutraceutical Excipients Market Report 2026
https://www.thebusinessresearchcompany.com/report/nutraceutical-excipients-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model